Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing carvedilol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol adverse reaction |
Causative agent (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to carvedilol (finding) |
Causative agent (attribute) |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 3.125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 6.25mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 10mg controlled release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 20mg controlled release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 40mg controlled release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 80mg controlled release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol phosphate (substance) |
Is a |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to carvedilol (finding) |
Causative agent (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol therapy (procedure) |
Direct substance |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carvedilol 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 3.125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 3.125 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 6.25mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 6.25mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Administration of carvedilol (procedure) |
Direct substance |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol phosphate (substance) |
Is modification of (attribute) |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carvedilol 12.5 mg oral tablet |
Has precise active ingredient |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 25 mg oral tablet |
Has precise active ingredient |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 3.125 mg oral tablet |
Has precise active ingredient |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol 6.25mg tablet (substance) |
Has precise active ingredient |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carvedilol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carvedilol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |